Better Controls for Covid-19 Diagnostics
Engineered recombinant antibodies offer advantages over serum-based controls.
Read MorePosted by Laurie Bonner | Nov 4, 2020 | Covid 19, Immunoassay Reagents & test Kits |
Engineered recombinant antibodies offer advantages over serum-based controls.
Read MorePosted by Laurie Bonner | Nov 4, 2020 | Covid 19, Immunoassay |
In a letter to clinical lab staff and healthcare providers, FDA offers recommendations for the proper use of antigen tests for covid-19.
Read MorePosted by Laurie Bonner | Nov 2, 2020 | Company News, Miscellaneous |
From CEOs to Nobel laureates, women are making their mark in the clinical sciences.
Read MorePosted by Laurie Bonner | Nov 2, 2020 | Covid 19, Immunoassay |
A new mathematical approach to screening large groups for covid-19 could be around 20 times cheaper than individual testing, researchers suggest.
Read MorePosted by Melanie Hamilton-Basich | Oct 30, 2020 | Covid 19 |
Researchers have created a surface that repels every other element of human blood except one critical cytokine to help understand the progress of covid-19 in individual patients.
Read More